Thursday, April 20, 2023 1:13:17 AM
First off, I do not profess to know more about "drugs" than anyone here or the World Wide Web.
Second, we are on the same page.
I have not "compared" Bellus Health to Algernon Pharmaceuticals Inc.
This is what I said:
It's the "CEO" of Algernon whose consistently made such a comparison to Bellus Health.
Point the finger(s) at Christopher Moreau (CEO @ Algernon Pharmaceuticals Inc.) not at me or anyone else.
I also listed a litany of historical fumbles and bumbles (I could list a 100 more E Z) at the hand of Christopher J. Moreau (CEO) since taking control of Algernon Pharmaceuticals Inc (formerly Breathtec Biomedical Inc) - Circa 2018. Over 5 years ago!
I'd be fascinated to see/read any serious counter argument to any of the Bullet Points I laid out in E Z LEE understood terminology.
Bulletproof
Hav @ It
M$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM